Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD2 | P14416 | 2/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1038441 | 0.93 | DRD2 (0.64) | DRD2 | |
| SCHEMBL29678818 | 0.93 | DRD2 (0.64) | DRD2 | |
| SCHEMBL22163345 | 0.92 | DRD2 (0.62) | DRD2 | |
| SCHEMBL1037463 | 0.92 | DRD2 (0.62) | DRD2 | |
| SCHEMBL4328789 | 0.90 | DRD2 (0.60) | DRD2 | |
| SCHEMBL31438780 | 0.83 | MEN1 (0.62) | DRD2 | |
| SCHEMBL1036238 | 0.83 | MEN1 (0.62) | DRD2 | |
| SCHEMBL20512980 | 0.83 | DRD2 (0.81) | DRD2 | |
| SCHEMBL29786358 | 0.83 | DRD2 (0.81) | DRD2 | |
| SCHEMBL20512939 | 0.82 | DRD2 (1.00) | DRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220048887-A1 | IMPURITIES OF AMIDE-LIKE DERIVATIVES AND USE THEREOF | NHWA PHARMA. CORPORATION (CN) | 2022-02-17 | — | — | US | disclosed |
| US-20220048887-A1 | IMPURITIES OF AMIDE-LIKE DERIVATIVES AND USE THEREOF | NHWA PHARMA. CORPORATION (CN) | 2022-02-17 | — | — | US | disclosed |
| EP-3901149-A1 | IMPURITIES OF AMIDE DERIVATIVES AND USE THEREOF | NHWA Pharma Corporation (CN) | 2021-10-27 | — | — | EP | disclosed |
| EP-3901149-A1 | IMPURITIES OF AMIDE DERIVATIVES AND USE THEREOF | NHWA Pharma Corporation (CN) | 2021-10-27 | — | — | EP | disclosed |
| CN-113195486-A | Impurities of amide derivatives and application thereof | 江苏恩华药业股份有限公司 | 2021-07-30 | — | — | CN | disclosed |
| WO-2020125580-A1 | IMPURITIES OF AMIDE DERIVATIVES AND USE THEREOF | 江苏恩华药业股份有限公司 | 2020-06-25 | — | — | WO | disclosed |
| WO-2020125580-A1 | IMPURITIES OF AMIDE DERIVATIVES AND USE THEREOF | 江苏恩华药业股份有限公司 | 2020-06-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220048887-A1 | IMPURITIES OF AMIDE-LIKE DERIVATIVES AND USE THEREOF | NOTUM, CYP51A1, HADHB | DRD2 2480/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.